Product image of Niquitin Mini (Nicotine) supplied by GNH India

Niquitin Mini

Active Ingredient:
Nicotine
Origin:
EU

Niquitin Mini (Nicotine)

Nicotine, the active ingredient in Niquitin Mini, is a nicotine replacement therapy presented as an oromucosal formulation for oromucosal use. It is intended to aid adult smokers in reducing cravings and withdrawal symptoms associated with tobacco cessation, providing a controlled dose of nicotine to support the quitting process.

GNH India supplies Niquitin Mini as a licensed, GDP‑compliant international pharmaceutical supplier serving pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable logistics for global distribution. Customers benefit from consistent product availability and regulatory compliance across markets.

Manufacturer / TM Owner

Chefaro Ireland Designated Activity Company

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Niquitin Mini is used as a nicotine replacement therapy to assist individuals who are trying to quit tobacco.

  • Smoking cessation: helps adult smokers reduce cravings and withdrawal symptoms during the quitting process.
  • Tobacco dependence: provides a controlled nicotine dose to lessen the urge to smoke.
  • Relapse prevention: supports individuals who have recently quit by managing occasional nicotine cravings.

How It Works

  • Nicotine acts as an agonist at nicotinic acetylcholine receptors in the central nervous system. By stimulating these receptors, it partially mimics the pharmacologic effects of tobacco‑derived nicotine, thereby reducing the intensity of withdrawal symptoms and cravings while the user gradually reduces dependence on smoked nicotine.

Side Effects

Niquitin Mini may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects

  • Mouth irritation or soreness.
  • Nausea or upset stomach.
  • Throat discomfort.
  • Headache.
  • Dizziness.
  • Increased salivation.

Serious or Rare Side Effects

  • Severe allergic reaction (anaphylaxis) with rash, swelling, or difficulty breathing.
  • Persistent high blood pressure.
  • Cardiac arrhythmia.
  • Severe nausea or vomiting leading to dehydration.
  • Unexplained weight loss.
  • Mood changes such as depression or anxiety.

Precautions & Warnings

Before using Niquitin Mini, consider the following safety measures.

  • Assess medical history: disclose cardiovascular disease, hypertension, or diabetes.
  • Avoid use in children: not intended for individuals under the legal smoking age.
  • Monitor for allergic reactions: discontinue if rash, swelling, or breathing difficulty occurs.
  • Caution with other nicotine sources: avoid simultaneous use of cigarettes, e‑cigarettes, or other NRT products.
  • Store at ambient temperature: keep below 25°C in the original packaging, protect from moisture and direct sunlight.

Avoid Interactions

Niquitin Mini can interact with certain medications and substances.

Major Interactions (Avoid)

  • Monoamine oxidase inhibitors (MAOIs): may increase nicotine effects and cardiovascular risk.
  • Certain antihypertensives: nicotine can counteract blood‑pressure‑lowering effects.

Moderate Interactions (Monitor Closely)

  • Caffeine‑containing products: may enhance stimulant effects, leading to jitteriness.
  • Psychiatric medications (e.g., antipsychotics): nicotine may alter drug metabolism.
  • Alcohol: combined use can increase nausea and dizziness.
  • Herbal supplements affecting liver enzymes (e.g., St. John’s wort): may modify nicotine clearance.

Frequently Asked Questions

Niquitin Mini is an over‑the‑counter nicotine replacement therapy designed to help adult smokers reduce cravings and withdrawal symptoms when they stop using tobacco. It provides a controlled dose of nicotine through the oral mucosa, supporting the quitting process and decreasing the likelihood of relapse.

Nicotine in Niquitin Mini binds to nicotinic acetylcholine receptors in the brain, partially stimulating the same pathways activated by cigarette smoke. This reduces the intensity of withdrawal symptoms and cravings, allowing the user to gradually wean off nicotine while maintaining some of the neurochemical effects that reduce discomfort.

The appropriate dose of Niquitin Mini is determined by the prescribing health professional based on the individual’s smoking history, level of dependence, and overall health status. Patients should follow the prescriber’s instructions and not exceed the recommended amount.

Safety data for nicotine replacement therapy during pregnancy and lactation are limited. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss the risks and benefits with their healthcare provider before using Niquitin Mini, as nicotine exposure may affect fetal development and infant health.

To request Niquitin Mini, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.

Niquitin Mini delivers nicotine via an oromucosal route, which can provide faster absorption than patches but a slower onset than inhaled forms. Compared with nicotine gum, it may be less irritating to the gums and offers a discreet dosing option. Choice of product depends on personal preference, tolerance, and the guidance of a healthcare professional.

Store Niquitin Mini at ambient temperature, preferably below 25 °C. Keep the product in its original packaging, protect it from moisture, direct sunlight, and extreme heat. Do not refrigerate or freeze unless specifically instructed by the manufacturer.

Niquitin Mini is administered by placing the product against the oral mucosa, allowing it to dissolve or release nicotine as directed by the prescriber. Users should avoid swallowing the entire dose at once and follow the recommended frequency to maintain steady nicotine levels while reducing cravings.

Serious risks include severe allergic reactions such as anaphylaxis, significant increases in blood pressure, cardiac arrhythmias, and persistent nausea or vomiting that may lead to dehydration. If any of these symptoms occur, discontinue use immediately and seek medical attention.

Niquitin Mini should be avoided by individuals with known hypersensitivity to nicotine or any excipients, children and adolescents who are not legally permitted to use tobacco products, and patients with uncontrolled cardiovascular disease unless advised otherwise by a qualified healthcare professional.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Nicotine

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT